Literature DB >> 10386970

Increased AP-1 DNA binding activity in PC12 cells treated with lead.

T Chakraborti1, K A Kim, G G Goldstein, J P Bressler.   

Abstract

The possibility that the mechanism of lead neurotoxicity may be at the level of transcription was investigated in PC12 cells. In electrophoretic mobility gel shift assays Pb2+ was found to increase activator protein-1 complex (AP-1) DNA binding activity in PC12 cells; the increase was time- and concentration-dependent. Exposure to Pb2+ also resulted in an increase in AP-1-driven transcription in cerebellar granule cells transfected with a luciferase gene reporter construct. The increase in AP-1 DNA binding activity by Pb2+ required protein synthesis. The increase was mediated by protein kinase C because depletion of protein kinase C and an inhibitor of protein kinase C prevented the increase in AP-1 DNA binding activity by Pb2+. Fra-2 and JunD were found in supershift assays to be the major components of the AP-1 that was increased by Pb2+. In summary, our studies indicate that Pb2+ increases AP-1 DNA binding activity in PC12 cells by a pathway that requires protein kinase C and new protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386970     DOI: 10.1046/j.1471-4159.1999.0730187.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier, in vitro.

Authors:  Lewis Zhichang Shi; Wei Zheng
Journal:  Hum Exp Toxicol       Date:  2007-03       Impact factor: 2.903

2.  The involvement of lipid activators of protein kinase C in the induction of ZIF268 in PC12 cells exposed to lead.

Authors:  Luisa Olivi; Jeanne Sisk; Joseph Bressler
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  Increased AP-1 DNA-binding activity and nuclear REF-1 accumulation in lead-exposed primary cultures of astrocytes.

Authors:  M Scortegagna; I Hanbauer
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.